Physician

Stanley J Whitney, M.D.

According to 2025 Medicare claims, Stanley Whitney, M.D. (NPI: 1942306824) practices neurology in the Tallahassee, FL market, with the plurality of this provider's patient population coming from Leon, FL. This provider's primary affiliated billing organization is TALLAHASSEE NEUROLOGY ASSOCIATES, P.A. (NPI: 1013013929; TIN: 010715267) and primary practice location at 32308-5469.

Whitney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 451 traditional Medicare patients, billed 2,666 HCPCS/CPT codes, and received $159,344 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,399 prescription claims across 367 beneficiaries totaling $541,820 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). 2019 DME data shows 20 claims. Open Payments data shows 112 records totaling $2,209. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $12,265 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	582	1,966	$138,391
2016	588	1,896	$149,638
2017	544	1,495	$115,148
2018	496	1,388	$114,919
2019	487	1,403	$119,276
2020	435	1,082	$89,959
2021	450	1,149	$102,177
2022	404	1,014	$95,714
2023	461	1,146	$100,278
2024	451	2,666	$159,344

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	298	2,392	$520,664
2016	293	2,480	$555,286
2017	321	2,341	$453,842
2018	310	2,192	$586,661
2019	296	2,210	$602,308
2020	306	2,226	$491,559
2021	299	2,178	$327,689
2022	312	2,093	$405,252
2023	330	2,162	$505,166
2024	367	2,399	$541,820

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	18	18	$1,246
2016	14	26	$936
2017	27	27	$1,238
2018	14	14	$834
2019	17	20	$1,152
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	68	70	$133
95819	Measurement of brain wave activity (eeg), awake and asleep	100	111	$132
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	86	86	$117
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	74	121	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	273	429	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	14	366	$69,514
Emgality Pen	Galcanezumab-Gnlm	67	2,040	$46,369
Nurtec Odt	Rimegepant Sulfate	20	552	$33,490
Topamax	Topiramate	13	390	$18,995
Briviact	Brivaracetam	14	392	$18,184

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	112	$2,209	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stanley J. Whitney, M.D.?

Tedicare shows public-source Medicare data for Stanley J. Whitney, M.D. (NPI 1942306824), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stanley J. Whitney, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stanley J. Whitney, M.D.?

Stanley J. Whitney, M.D. is linked to TALLAHASSEE NEUROLOGY ASSOCIATES, P.A. (billing NPI 1013013929) in the available physician profile data.

Does Stanley J. Whitney, M.D. have Open Payments data?

Stanley J. Whitney, M.D. has 112 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.